Welcome to LookChem.com Sign In|Join Free

CAS

  • or

53911-68-5

Post Buying Request

53911-68-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

53911-68-5 Usage

Description

BETA-(4-CHLOROPHENYL)GLUTARIC ANHYDRIDE, also known as 3-(4-Chlorophenyl)glutaric Anhydride, is an organic compound with the CAS number 53911-68-5. It is a white solid and is primarily used in the field of organic synthesis due to its unique chemical properties.

Uses

Used in Organic Synthesis:
BETA-(4-CHLOROPHENYL)GLUTARIC ANHYDRIDE is used as a synthetic intermediate for the production of various pharmaceuticals and chemicals. Its chemical structure allows it to be a versatile building block in the synthesis of complex molecules, contributing to the development of new drugs and materials.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, BETA-(4-CHLOROPHENYL)GLUTARIC ANHYDRIDE is used as a key component in the development of new drugs. Its unique properties enable it to be incorporated into the molecular structure of potential therapeutic agents, enhancing their efficacy and selectivity.
Used in Chemical Industry:
BETA-(4-CHLOROPHENYL)GLUTARIC ANHYDRIDE is also utilized in the chemical industry for the production of various chemicals and materials. Its reactivity and structural features make it a valuable compound for the synthesis of specialty chemicals, additives, and other industrial products.

Check Digit Verification of cas no

The CAS Registry Mumber 53911-68-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,3,9,1 and 1 respectively; the second part has 2 digits, 6 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 53911-68:
(7*5)+(6*3)+(5*9)+(4*1)+(3*1)+(2*6)+(1*8)=125
125 % 10 = 5
So 53911-68-5 is a valid CAS Registry Number.
InChI:InChI=1/C22H20Cl2O7/c23-17-5-1-13(2-6-17)15(9-19(25)26)11-21(29)31-22(30)12-16(10-20(27)28)14-3-7-18(24)8-4-14/h1-8,15-16H,9-12H2,(H,25,26)(H,27,28)

53911-68-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-(4-Chlorophenyl)dihydro-2H-pyran-2,6(3H)-dione

1.2 Other means of identification

Product number -
Other names β-(4-CHLOROPHENYL)GLUTARIC ANHYDRIDE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:53911-68-5 SDS

53911-68-5Relevant articles and documents

Glycinamide derivative as well as preparation method and application thereof

-

Paragraph 0013; 0041-0044; 0045-0046; 0047-0048; 0049; ..., (2021/06/12)

The invention discloses a glycinamide derivative as well as a preparation method and application thereof. The derivative with a structural formula as shown in the following formula (I) is provided; and in the formula, R1 is selected from Cl and H, R2 is one selected from H, CH3 and CH2CH3; and X is one selected from NHCH3, NHCH2CH3, N (CH2CH3) 2, a pyrrolyl group and a piperidyl group. During preparation, different phenyl glutaric acid compounds are selected as raw materials and are respectively subjected to amidation reaction twice with an aminoindane hydrochloride derivative and an ethylenediamine derivative to obtain a target derivative. The prepared derivative or the pharmaceutically acceptable salt thereof, or the pharmaceutical composition thereof can be used as an S-adenosyl homocysteine hydrolase inhibitor for the development of antitumor drugs .

ALLOSTERIC PROTEIN KINASE MODULATORS

-

Page/Page column 25, (2012/03/10)

The invention provides specific small molecule compounds that allosterically regulate the activity or modulate protein-protein interactions of AGC protein kinases and the Aurora family of protein kinases, methods for their production, pharmaceutical compositions comprising same, and their use for preparing medicaments for the treatment and prevention of diseases related to abnormal activities of AGC protein kinases or of protein kinases of the Aurora family.

ALLOSTERIC PROTEIN KINASE MODULATORS

-

Page/Page column 52, (2010/04/30)

The invention provides specific small molecule compounds that allosterically regulate the activity or modulate protein-protein interactions of AGC protein kinases and the Aurora family of protein kinases, methods for their production, pharmaceutical compositions comprising same, and their use for preparing medicaments for the treatment and prevention of diseases related to abnormal activities of AGC protein kinases or of protein kinases of the Aurora family.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 53911-68-5